Grapefruit USA, Inc

Grapefruit USA, Inc.

Drug Manufacturers - Specialty & Generic Healthcare Wilmington, DE, United States GPFT (PNK)

Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products in California. It primarily provides Hourglass, a time release THC+CBD-infused topical cream through online store. The company was formerly known as Grapefruit Boulevard Investments, Inc. and changed its name to Grapefruit USA, Inc. in January 2020. Grapefruit USA, Inc. was founded in 2017 and is based in Wilmington, Delaware.

Stock Performance (90 Days)

Data through Dec 30, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Drug Manufacturers - Specialty & Generic Companies

View All →

Frequently Asked Questions

Has Grapefruit USA, Inc had layoffs?
No layoff events have been recorded for Grapefruit USA, Inc in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Grapefruit USA, Inc have?
Grapefruit USA, Inc has approximately 9 employees.
What industry is Grapefruit USA, Inc in?
Grapefruit USA, Inc operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is Grapefruit USA, Inc a publicly traded company?
Yes, Grapefruit USA, Inc is publicly traded under the ticker symbol GPFT on the PNK. The company has a market capitalization of approximately $0.00 billion.
Where is Grapefruit USA, Inc headquartered?
Grapefruit USA, Inc is headquartered in Wilmington, DE, United States at 1000 Northwest Street, Wilmington, DE 19801, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.